| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/01/2011 | CN102078373A Traditional Chinese medicinal composition for treating incised wounds, empyrosis and various wounds |
| 06/01/2011 | CN102078323A Minodronate-containing pharmaceutical composition |
| 06/01/2011 | CN102078314A Medicament for treating cardiovascular disease and method preparing same |
| 06/01/2011 | CN102078292A Collagen oral liquid with improved bioavailability |
| 06/01/2011 | CN101756761B Heating patch with coupling agent and preparation process thereof |
| 06/01/2011 | CN101732691B Externally applied medicament for preventing and/or treating spondylodynia, osteoarthrosis and gout |
| 06/01/2011 | CN101554435B Traditional chinese medicine tea |
| 06/01/2011 | CN101537168B Traditional Chinese medicine composition for treatment of cervical spondylopathy and osteoarticular diseases and preparation method thereof |
| 06/01/2011 | CN101537050B Health product capable of enhancing bone density and immune function, and preparation method and applications thereof |
| 06/01/2011 | CN101411705B Pharmaceutical composition for preventing and treating atherosclerosis |
| 06/01/2011 | CN101342244B Traditional Chinese medicine bone setting powder for treating rheumatism bone disease based on hot-salt method |
| 06/01/2011 | CN101337014B Traditional Chinese medicine patch for treating internal and external injury |
| 06/01/2011 | CN101002873B Medicine for treating recurrent gout, and its preparing method |
| 05/31/2011 | US7951972 Human adam-10 inhibitors |
| 05/31/2011 | US7951820 Triazole compounds useful as protein kinase inhibitors |
| 05/31/2011 | US7951812 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007) |
| 05/31/2011 | US7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/31/2011 | CA2492739C Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/31/2011 | CA2475764C New inhibitors of histone deacetylase |
| 05/31/2011 | CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2369725C Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 05/27/2011 | CA2723119A1 Pharmaceutical compound comprising a strontium salt, vitamin d and a cyclodextrin |
| 05/26/2011 | WO2011063394A2 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 05/26/2011 | WO2011063241A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 05/26/2011 | WO2011062953A1 Use of eggshell membrane formulations to alleviate joint pain |
| 05/26/2011 | WO2011062765A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | WO2011062561A1 The isolation and characterisation of heparan sulphates and their use in pharmaceutical compositions, methods of treatment and stem cell culture media suitable for conditions associated with bone repair. |
| 05/26/2011 | WO2011062073A1 Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis |
| 05/26/2011 | WO2011061744A2 Novel arylated camphenes, processes for their preparation and uses thereof |
| 05/26/2011 | WO2011060553A1 Formulation and method for rapid preparation of isotonic and cytocompatible chitosan solutions without inducing chitosan precipitation |
| 05/26/2011 | WO2011022532A9 Methods for concomitant administration of colchicine and a second active agent |
| 05/26/2011 | WO2011002814A3 Sulfonamido - biphenyloxyacetic acid compounds |
| 05/26/2011 | WO2010131922A4 Amide compound, preparation method thereof and pharmaceutical composition comprising same |
| 05/26/2011 | WO2010053600A3 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 05/26/2011 | US20110126299 Triple transgenic mouse model of autoimmune disease and nf-kappa b in vivo imaging |
| 05/26/2011 | US20110124742 Composition and method of adipose cell differentiation inhibition |
| 05/26/2011 | US20110124720 Compositions and methods for treating immune disorders |
| 05/26/2011 | US20110124719 Composition for promoting production of hyaluronic acid containing kaempferol and quercetin |
| 05/26/2011 | US20110124717 Methods for Bone Treatment by Modulating an Arachidonic Acid Metabolic or Signaling Pathway |
| 05/26/2011 | US20110124712 Anti-cancer composition comprising microrna molecules |
| 05/26/2011 | US20110124705 Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof |
| 05/26/2011 | US20110124702 Nanosuspension of a Poorly Soluble Drug via Microfluidization Process |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124666 3,4-dihydropyrimidine trpa1 antagonists |
| 05/26/2011 | US20110124664 Polycationic Compounds And Uses Thereof |
| 05/26/2011 | US20110124653 Aryl-sulphonamidic dimers as metalloproteases inhibitors |
| 05/26/2011 | US20110124650 Stable crystalline salts of antifolate compounds |
| 05/26/2011 | US20110124641 Benzothiazole kinase inhibitors and methods of use |
| 05/26/2011 | US20110124640 Fused heterocyclic compounds useful as kinase modulators |
| 05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 05/26/2011 | US20110124611 Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
| 05/26/2011 | US20110124610 Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k |
| 05/26/2011 | US20110124570 Fish protein hydrolysate having a bone-stimulating and maintaining activity, nutraceutical and pharmacological compositions comprising such a hydrolysate and method for obtaining same |
| 05/26/2011 | US20110124569 Macrocyclic compounds, protease inhibition, and methods of treatment |
| 05/26/2011 | US20110124567 Therapeutic compounds and methods |
| 05/26/2011 | US20110124562 Apoaequorin-containing compositions and methods of using same |
| 05/26/2011 | US20110123646 Extracts Obtained from Cell Line Cultures from Plants Belonging to the Oleaceae Family (e.g. Syringa Vulgaris), Their Preparation and Use |
| 05/26/2011 | US20110123619 Buccal delivery system |
| 05/26/2011 | US20110123554 Uses of immunoconjugates targeting cd138 |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123531 Combination therapy |
| 05/26/2011 | US20110123525 Anti-angiogenic therapy |
| 05/26/2011 | US20110123449 Solid Forms of N-(4-(7-Azabicyclo[2.2.1]Heptan-7-yl)-2-Trifluoromethyl)Phenyl)-4-Oxo-5-(Trifluoromethyl)-1,4-Dihydroquinoline-3-Carboxamide |
| 05/26/2011 | US20110123435 Compounds for inhibiting ksp kinesin activity |
| 05/26/2011 | DE102009052808A1 Ointment, useful e.g. for treating salt deficiency, acute and chronic trauma, comprises ointment base and homeopathically diluted mineral salt including e.g. calcium phosphate, iron phosphate, potassium chloride and potassium phosphate |
| 05/26/2011 | CA2780777A1 2,4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 05/26/2011 | CA2780756A1 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 05/26/2011 | CA2780333A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | CA2774868A1 Novel arylated camphenes, processes for their preparation and uses thereof |
| 05/26/2011 | CA2770340A1 Preventive and/or therapeutic and/or aggravation suppressing agent for human arthritis deformans |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325300A1 Desaturase genes and uses thereof |
| 05/25/2011 | EP2325198A1 Compositions and methods for the therapeutic use of an atonal-associated sequence |
| 05/25/2011 | EP2325181A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 05/25/2011 | EP2324851A1 Methods of administering anti-TNFalpha antibodies |
| 05/25/2011 | EP2324825A1 Aryl ureas with angiogenesis inhibiting activity |
| 05/25/2011 | EP2324041A2 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections |
| 05/25/2011 | EP2324022A1 Substituted naphthyridines and use thereof as medicines |
| 05/25/2011 | EP2324018A1 Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1 |
| 05/25/2011 | EP2324017A2 INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1 |
| 05/25/2011 | EP2324015A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 05/25/2011 | EP2323983A1 Piperidinyl derivative as a modulator of chemokine receptor activity |
| 05/25/2011 | EP2323641A2 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| 05/25/2011 | EP2323638A1 Compositions and methods for treating osteoarthritis |
| 05/25/2011 | EP2021335B1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 05/25/2011 | EP1868994B1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 05/25/2011 | EP1755620B1 Sulphated depolymerised exopolysaccharide derivatives, their preparation and uses |
| 05/25/2011 | EP1425035B1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 05/25/2011 | EP1349562B1 Inhibiting gs-fdh to modulate no bioactivity |
| 05/25/2011 | EP1317454B1 Caspase inhibitors and uses thereof |
| 05/25/2011 | EP1263463B1 Use of an antibody or an immunotoxin that selectively binds to cd123 to impair hematologic cancer progenitor cells |
| 05/25/2011 | CN1976690B Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis |
| 05/25/2011 | CN1903159B Cosmetic sheet |
| 05/25/2011 | CN102076682A Five-membered ring compound |
| 05/25/2011 | CN102076672A Novel five-membered ring compound |
| 05/25/2011 | CN102076671A Triazole derivative or salt thereof |
| 05/25/2011 | CN102076663A Piperidinyl derivative as modulator of chemokine receptor activity |